204 related articles for article (PubMed ID: 25880038)
1. Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment.
Suarez-Carmona M; Bourcy M; Lesage J; Leroi N; Syne L; Blacher S; Hubert P; Erpicum C; Foidart JM; Delvenne P; Birembaut P; Noël A; Polette M; Gilles C
J Pathol; 2015 Aug; 236(4):491-504. PubMed ID: 25880038
[TBL] [Abstract][Full Text] [Related]
2. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cells promote triple-negative breast cancer cell metastasis
Zhang W; Xu J; Fang H; Tang L; Chen W; Sun Q; Zhang Q; Yang F; Sun Z; Cao L; Wang Y; Guan X
FASEB J; 2018 Jan; 32(1):276-288. PubMed ID: 28899878
[TBL] [Abstract][Full Text] [Related]
4. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
[TBL] [Abstract][Full Text] [Related]
5. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment modifications induced by soluble VEGF receptor expression in a rat liver metastasis model.
Bertin S; Mohsen-Kanson T; Baqué P; Gavelli A; Momier D; Anjuere F; Carle GF; Pierrefite-Carle V
Cancer Lett; 2010 Dec; 298(2):264-72. PubMed ID: 20702033
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic activity of mesenchymal stem cells in multiple myeloma.
Wang X; Zhang Z; Yao C
Cancer Invest; 2011 Jan; 29(1):37-41. PubMed ID: 21166497
[TBL] [Abstract][Full Text] [Related]
8. Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling.
Liu G; Chen Y; Qi F; Jia L; Lu XA; He T; Fu Y; Li L; Luo Y
J Pathol; 2015 Oct; 237(2):190-202. PubMed ID: 25988668
[TBL] [Abstract][Full Text] [Related]
9. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro.
Han EC; Lee J; Ryu SW; Choi C
Biochem Biophys Res Commun; 2014 Jan; 443(4):1218-25. PubMed ID: 24388986
[TBL] [Abstract][Full Text] [Related]
10. M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases.
Vinnakota K; Zhang Y; Selvanesan BC; Topi G; Salim T; Sand-Dejmek J; Jönsson G; Sjölander A
J Cell Physiol; 2017 Dec; 232(12):3468-3480. PubMed ID: 28098359
[TBL] [Abstract][Full Text] [Related]
11. Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.
Tu M; Lu C; Lv N; Wei J; Lu Z; Xi C; Chen J; Guo F; Jiang K; Li Q; Wu J; Song G; Wang S; Gao W; Miao Y
Cancer Lett; 2016 Dec; 383(2):272-281. PubMed ID: 27702660
[TBL] [Abstract][Full Text] [Related]
12. YBX1/YB-1 induces partial EMT and tumourigenicity through secretion of angiogenic factors into the extracellular microenvironment.
Gopal SK; Greening DW; Mathias RA; Ji H; Rai A; Chen M; Zhu HJ; Simpson RJ
Oncotarget; 2015 May; 6(15):13718-30. PubMed ID: 25980435
[TBL] [Abstract][Full Text] [Related]
13. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells.
Fernando RI; Castillo MD; Litzinger M; Hamilton DH; Palena C
Cancer Res; 2011 Aug; 71(15):5296-306. PubMed ID: 21653678
[TBL] [Abstract][Full Text] [Related]
14. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
[TBL] [Abstract][Full Text] [Related]
15. SMC1 promotes epithelial-mesenchymal transition in triple-negative breast cancer through upregulating Brachyury.
Li K; Ying M; Feng D; Chen Y; Wang J; Wang Y
Oncol Rep; 2016 Apr; 35(4):2405-12. PubMed ID: 26781859
[TBL] [Abstract][Full Text] [Related]
16. Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretion.
Vanni C; Ognibene M; Finetti F; Mancini P; Cabodi S; Segalerba D; Torrisi MR; Donnini S; Bosco MC; Varesio L; Eva A
Cell Cycle; 2015; 14(9):1426-37. PubMed ID: 25723869
[TBL] [Abstract][Full Text] [Related]
17. Modulation of endothelial cell network formation in vitro by molecular signaling of head and neck squamous cell carcinoma (HNSCC) exposed to cetuximab.
Jouan-Hureaux V; Boura C; Merlin JL; Faivre B
Microvasc Res; 2012 Mar; 83(2):131-7. PubMed ID: 21820450
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and significance of epithelial-mesenchymal transition in breast cancer.
Roxanis I
J Clin Pathol; 2013 Jun; 66(6):517-21. PubMed ID: 23322823
[TBL] [Abstract][Full Text] [Related]
19. Jianpi-Tiaoqi decoction inhibits tumour proliferation and lung metastasis in tumour-bearing mice with triple-negative breast cancer.
Zhang J; Ye CX; Chen HT; Li T; Ma LT; Guo Y
Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13900. PubMed ID: 38843865
[TBL] [Abstract][Full Text] [Related]
20. Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.
Donzelli S; Milano E; Pruszko M; Sacconi A; Masciarelli S; Iosue I; Melucci E; Gallo E; Terrenato I; Mottolese M; Zylicz M; Zylicz A; Fazi F; Blandino G; Fontemaggi G
Breast Cancer Res; 2018 Jun; 20(1):59. PubMed ID: 29921315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]